Has Wilson Szeto, MD received payments from drug or device companies?

Yes. Drug and device makers reported $251,821 in general payments to Wilson Szeto, MD across 437 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wilson Szeto, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wilson Szeto, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wilson Szeto, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Philadelphia, PANPI 1467497263

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Bolton Medical Inc at 45.0% of the total. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$251,821in general payments, 2019–2025

Across 437 payments — averaging $576.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bolton Medical Inc$113K
Edwards Lifesciences$57K
Artivion, Inc.$54K
Medtronic$24K
Abbott$3K
Atricure, Inc.$665
plus $1K from 8 others

$930,761in research payments, 2019–2025

Across 156 payments — averaging $5966.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Edwards Lifesciences$420K
Bolton Medical Inc$292K
Artivion, Inc.$162K
Boston Scientific$34K
Livanova USA, Inc.$14K
Medtronic$4K
plus $4K from 2 others

What the payments were for

Consulting fees$132,16352%
Speaking & faculty fees$47,35019%
Travel & lodging$40,81816%
Food & beverage$30,49012%
Education$1,0000%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bolton Medical Inc	139	$113,367
Edwards Lifesciences	132	$56,745
Artivion, Inc.	44	$53,511
Medtronic(2 entities)	78	$23,513
Abbott	14	$2,879
Atricure, Inc.	15	$665
Corcym Inc	4	$286
W. L. Gore & Associates, Inc.	1	$197
Livanova USA, Inc.	2	$178
Abiomed	2	$174
Baxter Healthcare	2	$133
Zimmer Biomet	1	$125
Smith+Nephew	2	$28
Boston Scientific	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TREO ABDOMINAL STENT-GRAFT SYSTEM$56,847
AMDS-Ascyrus Medical$39,521
THORAFLEX HYBRID$15,439
Edwards SAPIEN 3 Transcatheter Heart Valve$13,550
RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$12,637
Relay Plus$12,385
Avalus$7,992
Relay Grafts$7,813
Mosaic$7,327
Cardiac non-SynerGraft$3,317
INSPIRIS RESILIA aortic valve$2,912
Simulus$2,300
Grafts$2,047
Cardioblate$1,959
Epic$1,682
STENTS$948
CoreValve Evolut$944
TENDYNE$603
COREVALVE EVOLUT R$591
NAVITOR$431

How this compares

$251,821 in reported general payments places this provider in the 95th percentile of 314 thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$346,248

Medicare patients

312

Services billed

574

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Mupirocin	47	$321

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Philadelphia

Mark AndersonPhiladelphia$527K
Michael AckerPhiladelphia$271K
Nimesh DesaiPhiladelphia$203K
Nathaniel EvansPhiladelphia$187K
Marisa CevascoPhiladelphia$186K
Pavan AtluriPhiladelphia$165K
Chase BrownPhiladelphia$137K
Olugbenga OkusanyaPhiladelphia$132K
Michael IbrahimPhiladelphia$66K
Joshua GrimmPhiladelphia$56K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →